| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Neurochemistry (N.M., T.S., H.G.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892; Department of Medicine (J.G.V.), Division of Endocrinology and Metabolism, Georgetown University, Washington, D.C. 20007; and Laboratory of Genetics (C.C.X., M.J.B.), National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Harold Gainer, Ph.D., Laboratory of Neurochemistry, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892. E-mail: gainerh{at}ninds.nih.gov.
Hypoosmolality produces a dramatic inhibition of vasopressin (VP) and oxytocin gene expression in the supraoptic nucleus (SON). This study examines the effect of sustained hypoosmolality on global gene expression in the oxytocin and VP magnocellular neurons of the hypothalamo-neurohypophysial system, to identify genes associated with the magnocellular neurons adaptation to this physiological condition. Using laser microdissection of the SON, T7-based linear amplification of its RNA, and a 35,319-element cDNA microarray, we compare gene expression profiles between SONs in normoosmolar (control), 1-desamino-[8-D-arginine]-VP-treated normoosmolar, and hypoosmolar rats. We found 4959 genes with statistically significant differences in expression between normosmolar control and the hypoosmolar SONs, with 1564 of these differing in expression by more than 2-fold. These genes serve a wide variety of functions, and most were up-regulated in gene expression in hypoosmolar compared with control SONs. Of these, 90 were preferentially expressed in the SON, and 44 coded for transcription-related factors, of which 15 genes were down-regulated and 29 genes were up-regulated in the hypoosmolar rat SONs. None of these transcription-related factor genes significantly changed in expression after sustained 1-desamino-[8-D-arginine]-VP-treatment alone, indicating that these changes were associated with the hypoosmolar state and not due solely to a decreased activity in the SON. Quantitative in situ hybridization histochemistry was selectively used to confirm and extend these microarray observations. These results indicate that the hypoosmolar state is accompanied by a global, but selective, increase in expression of a wide variety of regulatory genes in the SON.
This article has been cited by other articles:
![]() |
J. Blechman, N. Borodovsky, M. Eisenberg, H. Nabel-Rosen, J. Grimm, and G. Levkowitz Specification of hypothalamic neurons by dual regulation of the homeodomain protein Orthopedia Development, December 15, 2007; 134(24): 4417 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rusnak, Z. E. Toth, S. B. House, and H. Gainer Depolarization and Neurotransmitter Regulation of Vasopressin Gene Expression in the Rat Suprachiasmatic Nucleus In Vitro J. Neurosci., January 3, 2007; 27(1): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Lee, M. Palkovits, and W. S. Young III From the Cover: miR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation PNAS, October 17, 2006; 103(42): 15669 - 15674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Uney and S. L. Lightman MicroRNAs and osmotic regulation PNAS, October 17, 2006; 103(42): 15278 - 15279. [Full Text] [PDF] |
||||
![]() |
C. Hindmarch, S. Yao, G. Beighton, J. Paton, and D. Murphy A comprehensive description of the transcriptome of the hypothalamoneurohypophyseal system in euhydrated and dehydrated rats PNAS, January 31, 2006; 103(5): 1609 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Ghorbel, G. Sharman, C. Hindmarch, K. G. Becker, T. Barrett, and D. Murphy Microarray screening of suppression subtractive hybridization-PCR cDNA libraries identifies novel RNAs regulated by dehydration in the rat supraoptic nucleus Physiol Genomics, January 12, 2006; 24(2): 163 - 172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |